Loading company…
Pfanstiehl Laboratories makes high-purity, injectable grade excipients for biopharmaceuticals and vaccines.
Based in Waukegan, US, Pfanstiehl Laboratories develops high-purity injectable excipients, branded HPLE-LM, for biopharmaceutical and vaccine production. Med Opportunity Partners acquired the company in April 2013 for USD 24.9 mn. The CEO is James Breckenridge.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in